Roche Diagnostics' AmpliChip(TM) CYP450 Test Now Available From LabCorp(R)

Identifies Genetic Variants in Drug-Metabolizing Enzymes to Help Physicians Manage Medication and Reduce Adverse Drug Reactions BURLINGTON, N.C., Nov. 28 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the availability of Roche

LabCorp(R) Launches Enhanced HIV Screening Assay

Revolutionary Procedure Helps Identify Newly Infected HIV Patients Up to Six Weeks Sooner than Standard HIV Antibody Screening BURLINGTON, N.C., Nov. 7 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the introduction of an enhanced HIV

LabCorp(R) Licenses Arcturus' Technology for Characterization of Tumor Cells of Unknown Primary Origin

Partnership Expands Access to New Diagnostic Tool for Cancer-treating Physicians BURLINGTON, N.C., Nov. 1 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), an industry leader in oncology testing, announced today that it has entered into an agreement

Laboratory Corporation of America(R) Announces 2005 Third Quarter Results

Revenue Increase of 9.1 Percent Drives Operating Cash Flow of $172 Million BURLINGTON, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and nine-months ended September 30, 2005.

Esoterix Expands Exclusive Testing Rights for SHOX Gene Testing

AUSTIN, Texas, Oct. 18 /PRNewswire-FirstCall/ -- Esoterix, a subsidiary of Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has expanded its exclusive rights for SHOX diagnostic testing services to include the European Union.

LabCorp to Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 28 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the UBS Global Life Sciences Conference in New York, NY.

LabCorp(R) Launches Comparative Genomic Hybridization Testing

BURLINGTON, N.C., Sept. 21 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it will begin offering Comparative Genomic Hybridization (CGH), a revolutionary new technology that provides physicians with the information necessary to

LabCorp Launches Its eLabCorp(SM) Web-Based Customer Connectivity Solution

BURLINGTON, N.C., Sept. 15 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the launch of "eLabCorp," its latest customer connectivity offering. eLabCorp has been designed to provide LabCorp customers with unparalleled compatibility and

LabCorp to Present at The Thomas Weisel Partners Healthcare Conference

BURLINGTON, N.C., Sept. 1 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad) Hayes, Executive Vice President and Chief Financial Officer, are

LabCorp(R) to Begin Validation and Evaluation of Roche Diagnostics' AmpliChip(TM) CYP450 Test

BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it will begin validation testing of Roche Diagnostics' AmpliChip(TM) CYP450 test. The AmpliChip(TM) CYP450 test has been cleared by the U.S.